Which diabetes pill is better? new study aims to find out
NCT ID NCT07311551
First seen Jan 05, 2026 · Last updated May 15, 2026 · Updated 24 times
Summary
This study compares two common diabetes drugs, dapagliflozin and empagliflozin, in adults with type 2 diabetes and a high body mass index. Researchers will measure changes in blood sugar, weight, liver and kidney function, blood pressure, and cost over six months. The goal is to find which drug works better, is safer, and is more affordable for patients in India.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.